The Dividend Yield as of December 2024 (TTM) for KalVista Pharmaceuticals, Inc. (KALV) is 0%

According to KalVista Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

KalVista Pharmaceuticals, Inc. (KALV) Historical Dividend Yield (quarterly & annually)

How has KALV Dividend Yield performed in the past?

The mean historical Dividend Yield of KalVista Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), KALV's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

KalVista Pharmaceuticals, Inc. (KALV) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of KalVista Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

KalVista Pharmaceuticals, Inc. (KALV) Average Dividend Yield

How has KALV Dividend Yield performed in the past?

The current Dividend Yield of KalVista Pharmaceuticals, Inc. (KALV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

KalVista Pharmaceuticals, Inc. (KALV) Dividend Yield vs. Peers

How is KALV’s Dividend Yield compared to its peers?

KalVista Pharmaceuticals, Inc.’s Dividend Yield is less than Crinetics Pharmaceuticals, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Kura Oncology, Inc. (0%), less than Viridian Therapeutics, Inc. (0%), less than Replimune Group, Inc. (0%), less than Nuvectis Pharma, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Kronos Bio, Inc. (0%), less than Gossamer Bio, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Cogent Biosciences, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Mersana Therapeutics, Inc. (0%), less than Immunocore Holdings plc (0%), less than Mirum Pharmaceuticals, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Cytokinetics, Incorporated (0%), less than DICE Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Karuna Therapeutics, Inc. (0%), less than Dyne Therapeutics, Inc. (0%),

Build a custom stock screener for KalVista Pharmaceuticals, Inc. (KALV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KalVista Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

KalVista Pharmaceuticals, Inc. (KALV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like KalVista Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.